![Page 1: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/1.jpg)
A riddle wrapped in a mystery inside an enigma
Jacques Genest MD
Cardiovascular Research Laboratories
McGill University Health Center
Metabolism and Protective
Properties of HDL
![Page 2: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/2.jpg)
Merck *
Pfizer
Novartis
AMGEN *
Roche *
AstraZeneca
Disclosure J. Genest MD 2013
Relevant disclosure: JUPITER, IMPROVE-IT, CANTOS , CAPREE steering Committees; REVEAL , ACCELERATE, AMG145 , Lilly Clinical Trials.
Advisory Board, Speaker’s Bureau, Consultant, Grants, Clinical Trials
Sanofi/Regeneron *
Lilly
Valeant
Genzyme *
Aegerion
Stock ownership: none;
Off label use: none
* Scientific Advisory
![Page 3: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/3.jpg)
The Controversy
A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease.
However, in randomized, controlled trials, high-dose niacin or inhibitors of cholesteryl ester transfer protein did not improve CV outcomes despite significantly increasing the HDL-C level.
Furthermore, genetic variants associated with HDL-C levels are often not associated with CVD.
These observations suggest that HDL cholesterol may not be causally associated with CVD
N Engl J Med 2014;371:2383-93.
![Page 4: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/4.jpg)
HDL Metabolism
Complexity of HDL
HDL Biogenesis
HDL Metabolism
![Page 5: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/5.jpg)
HDL Metabolism: The Simplified
View
Circ Res. 2014;114:171-182
![Page 6: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/6.jpg)
Human Plasma Lipidome (Quenhenburger N Engl J Med 2011;365:1812-23)
![Page 7: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/7.jpg)
Human Plasma Lipidome
![Page 8: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/8.jpg)
Apolipoprotein AI
![Page 9: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/9.jpg)
Adenosine Triphosphate Binding
Cassette Transporter A1 (ABCA1)
Full-transporter
Phospholipid and
(cholesterol) efflux to apoA-I
Early HDL maturation
LxR/RxR
- COOH
NH
2-
cholesterol
&
phospholipid
ATP ADP+Pi
apoA-I
ATP ADP+Pi
![Page 10: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/10.jpg)
Iatan I et al. JLR 2011
HDL Biogenesis Model
![Page 11: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/11.jpg)
HDL Biogenesis
![Page 12: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/12.jpg)
Nascent HDL Particles
Sorci-Thomas JLR 2012
![Page 13: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/13.jpg)
HDL Biogenesis
CE C
![Page 14: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/14.jpg)
Two-D PAGGE Analysis of HDL
- 17.0
- 12.2
- 7.1
[nm]
- 9.5
a - LpA - I
pre - b 1 - LpA - I
O a pre - b
- 17.0
- 12.2
- 7.1
[nm]
- 9.5
- 17.0
- 12.2
- 7.1
[nm]
- 9.5
Apo AI-containing
lipoproteins
a - LpA - I
pre - b 1 - LpA - I
O a pre - b
Hafiane A. CLC 2013 R17; P18
![Page 15: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/15.jpg)
Intestine
Liver
Endogenous Pathway
FFA
VLDL
ApoA-I, A-II ApoC-I, C-II, C-III Phospholipids Free cholesterol
ApoA-I, A-II ApoC-I, C-II, C-III Phospholipids Free cholesterol
Nascent HDL
Peripheral Cells
FFA
Free Cholesterol
HL
Liver
LCAT
HL Steroidogenic Cells
Exogenous Pathway Chylomicron
Chylo Remnant
HDL2 LDL
IDL
LPL
LPL
CETP PLTP
CE
Tg
HDL3
3 Liver
HL
Lipoprotein Metabolism
Feces
![Page 16: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/16.jpg)
HDL-C factors:
◦ Environmental
◦ Genetic: heritability 50%
Novel genes: PCSK5, WWOX
Known genes:
º Mutations in several genes have
identified (ApoAI, ABCA1, LCAT )
Kathiresan S, Cupples L et al. Nat Genet (2009) 41(1): 56-65
Genes involved in HDL regulation
16
![Page 17: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/17.jpg)
Cellular Cholesterol Efflux
Anti-oxidant
Anti-inflammatory
Vascular Endothelial function
Anti-thrombotic
HDL Functions
![Page 18: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/18.jpg)
Figure 1 Pleiotropic biological functions of apolipoprotein A-I
Shah, P. K. (2011) Targeting endogenous apo A-I—a new approach for raising HDL Nat. Rev. Cardiol. doi:10.1038/nrcardio.2011.37
![Page 19: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/19.jpg)
ABCA1 –Mediated Cellular Cholesterol Efflux
LxR/RxR
![Page 20: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/20.jpg)
HDL Cholesterol efflux:
Biomarker of CVD
N Engl J Med 2014;371:2383-93.
![Page 21: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/21.jpg)
CVD, HDL-C and Efflux Capacity
N Engl J Med 2014;371:2383-93.
![Page 22: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/22.jpg)
Cholesterol Efflux and CVD
Khera AV. N Engl J Med 2011;364:127-35
![Page 23: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/23.jpg)
Cholesterol Efflux and CVD
Arterioscler Thromb Vasc Biol. 2013;33:1696-1705
![Page 24: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/24.jpg)
* * B
*
ACS1 ACS2 CAD Control 0
2
4
6
8
10
12
14 25
50
75 290
300
hsC
RP
(m
g/L)
A
Hafiane A. CLC 2013 P10
HDL-Mediated Cellular Cholesterol Efflux in CAS
![Page 25: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/25.jpg)
*** ***
***
HDL-Mediated Cellular Cholesterol Efflux in CAS
Hafiane A. CLC 2013 P10
![Page 26: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/26.jpg)
Antioxidant Properties of HDL
![Page 27: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/27.jpg)
Antioxidant Properties of HDL
HDL
LDL-ox LDL
PL, FFA
PL-ox POVPC PGPC PAPC
Apo AI, J
LOOX CE-OOX
HOPDE HPETE
a-Toc
O2-
OH
Paraoxonase (PON) Glutathion peroxidase (GPX) PAF-acetyl hydrolase (PAF-AH) Lp-PLA2
12-Lipooxygenase
![Page 28: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/28.jpg)
Generation of truncated phospholipids by oxidative fragmentation and chemical synthesis.
Salomon R G Circulation Research. 2012;111:930-946
Copyright © American Heart Association, Inc. All rights reserved.
![Page 29: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/29.jpg)
POVPC activates aortic smooth muscle cell proliferation.
Salomon R G Circulation Research. 2012;111:930-946
Copyright © American Heart Association, Inc. All rights reserved.
![Page 30: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/30.jpg)
Prothrombotic activities of oxidatively truncated phospholipids.
Salomon R G Circulation Research. 2012;111:930-946
Copyright © American Heart Association, Inc. All rights reserved.
![Page 31: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/31.jpg)
Dehydrative cyclization of isoprostanoid hydroperoxy endoperoxides generates
epoxyisoprostanes.
Salomon R G Circulation Research. 2012;111:930-946
Copyright © American Heart Association, Inc. All rights reserved.
![Page 32: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/32.jpg)
No consensus has yet emerged on the proper biomarker of HDL anti-oxidant function.
Antioxidant Properties of HDL
![Page 33: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/33.jpg)
HDL exerts beneficial effects on VEC
Increase eNOS stability, mRNA and pNOS
Decrease in NF-kB-mediated inflammatory gene expression
Increases endothelial progenitor cells
Endothelial cells and HDL
![Page 34: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/34.jpg)
Campbell S, Genest J, 2012
HDL- Vascular endothelial Cell Interaction
![Page 35: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/35.jpg)
150
150
250
150
100
75
50
37
Loading controls (Ponceau S staining)
eNOS (pS1177: positive phosphorylation)
eNOS (pT495: negative phosphorylation) A
CS1
HD
L
AC
S2 H
DL
Me
diu
m 2
00
Hyp
o a
He
alth
y H
DL
HDL stimulation of Human Aortic Endothelial eNOS
Choi, H 2013 Unpublished
![Page 36: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/36.jpg)
Bessler et al. JCI 2011. Confocal microscopy of GFP-anti RelA/p65
HDLhealthy prevents NF-KB nuclear translocation/activation
![Page 38: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/38.jpg)
HDL and Endothelial Progenitor Cells
Sorrentino SA et al. Circulation 2010;121;110-122
![Page 39: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/39.jpg)
Circ Res. 2014;114:171-182
![Page 40: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/40.jpg)
Cholesterol efflux ABCA1, ABCG1 and SR-BI
Anti-infectious trypanosome lytic factor and LPS inactivation
Anti-apoptic recruitment of endothelial progenitor
cells (EPC)
Vasodilatory NO release, prostacyclin (PGI2) production and eNOS activation
Anti-inflammatory inhibit VCAM-1 expression and adhesion molecules
Antioxidative anti-oxLDL, inactivate LOOH
and oxPhospholipase
Anti-thrombotic inhibition of platelet aggregation and
prostacyclin (PGI2) production
HDL
Hafiane A. Cholesterol 2013
![Page 41: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/41.jpg)
The HDL Proteome
Over 200 proteins have been identified as part of the HDL proteome
(http://homepages.uc.edu/~davidswm/HDLproteome.html
![Page 42: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/42.jpg)
![Page 43: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/43.jpg)
-0.5 -0.4 -0.3 -0.2 -0.1 0.0 0.1 0.2 0.3 0.4
serum_amyloid_A_isotype_1_protein
alanyl_(membrane)_aminopeptidase
leucine-rich_alpha-2-glycoprotein_1
complement_component_4B
complement_factor_B
complement_component_3
profilin_1
apolipoprotein_L_1
fibrinogen_alpha_chain
apolipoprotein_C-IV
hemopexin
alpha-1_antiproteinase_antitrypsin
integrin_alpha_2b
chromosome_1_open_reading_frame_56
phospholipid_transfer_protein
haptoglobin-related_protein
apolipoprotein_C-II
inter-alpha_(globulin)_inhibitor_H4
vitronectin
prenylcysteine_oxidase_1
complement_component_1s
fibronectin_1
afamin
orosomucoid_2
alpha-1_antiproteinase_antitrypsin
alpha-1-B_glycoprotein
beta-2-microglobulin
surfactant_protein_B
isocitrate_dehydrogenase_3_(NAD+)_alpha
orosomucoid_1
ceruloplasmin_(ferroxidase)
C1_protease_inhibitor
apolipoprotein_H
alpha-1-microglobulin/bikunin_precursor
cathelicidin_antimicrobial_peptide
apolipoprotein_E
albumin
serum_amyloid_A4_constitutive
apolipoprotein_A-I
apolipoprotein_C-I
coagulat ion_factor_II_(thrombin)
transthyret in
apolipoprotein_C-III
paraoxonase_1
transferrin
heparin_cofactor
vitamin_D_binding_protein
apolipoprotein_F
lecithin-cholesterol_acyltransferase
glycosylphosphatidylinositol_specif ic_phospholipase_D1
apolipoprotein_A-II
apolipoprotein_D
apolipoprotein_M
paraoxonase_3
retinol binding protein 4
lumican
alpha-2-HS-glycoprotein
angiotensinogen
gelsolin
inter-alpha_(globulin)_inhibitor_H2
alpha-2-glycoprotein_1_zinc-binding
peptidoglycan_recognit ion_protein_2
cystat in_C
antithrombin
apolipoprotein_A-IV
mult imerin_2
carbonic_anhydrase_I
clusterin
Enriched in ACS Enriched in controls
![Page 44: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/44.jpg)
HDL Proteome in CVD
Riwanto M et al. Altered activation of endothelial anti- and proapoptotic pathways by
high-density lipoprotein from patients with coronary artery disease: role of high-density
lipoprotein-proteome remodeling. Circulation. 2013;127:891–904.
![Page 45: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/45.jpg)
Independent confirmation of differentially expressed proteins by Western analysis or ELISA
![Page 46: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/46.jpg)
Independent confirmation of differentially enriched proteins by Western analysis or ELISA - Controls
![Page 47: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/47.jpg)
Electron paramagnetic resonance spectroscopy (EPR)
PLoS One. 2013 Aug 28;8(8):e71541. doi: 10.1371/journal.pone.0071541.
![Page 48: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/48.jpg)
The HDL Lipidome
Specific lipid species may have a physiological role in HDL function
Kontush A et al. J. Lipid Res.
2013;54:2950-2963
![Page 49: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/49.jpg)
Physicochemical properties and lipid class composition of HDL particle subpopulations.
Kontush A et al. J. Lipid Res. 2013;54:2950-2963
©2013 by American Society for Biochemistry and Molecular Biology
![Page 50: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/50.jpg)
Specifically, the content of phosphatidylserine revealed positive correlations with all metrics of HDL functionality, reflecting enrichment of phosphatidylserine in small, dense HDL3.
![Page 51: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/51.jpg)
Campbell S, Genest J, 2012
HDL- Vascular endothelial Cell Interaction
![Page 52: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/52.jpg)
Cellular Cholesterol Efflux
Anti-oxidant
Anti-inflammatory
Vascular Endothelial function
Anti-thrombotic
The Challenge
Develop Biomarkers of HDL Function
That can be tested in outcome studies, be reproducible and brought to high throughput.
![Page 53: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/53.jpg)
HDL Biomarkers presently limited in predicting outcomes
IVUS may be the least bad surrogate currently available
New imaging modalities (18FDG) and PET/CT scanning
High bar of regulatory agencies
The Short Term
Identify Responders, Sub groups
![Page 54: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/54.jpg)
Need to identify new pathways of HDL biogenesis and metabolism
Study the structure of HDL in health and in disease (proteomics, lipidomics)
Design clinical trials that are highly focused (initially)
The Long Term
HDL is a Biologically SOUND Target
![Page 55: Metabolism and Protective Properties of HDL · 2020-02-13 · The Controversy A low level of HDL-C is a major independent risk factor for atherosclerotic cardiovascular disease. However,](https://reader035.vdocuments.net/reader035/viewer/2022070821/5f2335c7caf6787ab10816e7/html5/thumbnails/55.jpg)
Points to Take Home
HDL particles are complex
Genes involved in HDL biogenesis may make better therapeutic targets than genes involved in HDL remodeling (Lipases, CETP)
New Gene, new pathways